These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1566 related articles for article (PubMed ID: 31792354)

  • 1. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of targeting cancer stem cells to halt metastasis.
    Agliano A; Calvo A; Box C
    Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
    Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
    Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.
    Shigdar S; Lin J; Li Y; Yang CJ; Wei M; Zhus Y; Liu H; Duan W
    Ther Deliv; 2012 Feb; 3(2):227-44. PubMed ID: 22834199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune ligands for cytotoxic T Lymphocytes (CTLS) in cancer stem cells (CSCS).
    Voutsadakis IA
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):563-583. PubMed ID: 28930561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.